Cetacaine Topical Anesthetic Liquid

Cetacaine Liquid Sell Sheet
Click here to download
Cetacaine Liquid
Product Sheet

Cetacaine Liquid Instructions
Click here to download
Cetacaine Liquid
Instructions

Cetacaine MSDS
Click here to
request MSDS

Product Catalog
Click here to download
Product Catalog

 

Topical Anesthetics
  • New, unique dispenser cap is compatible with any Luer-lock syringe
  • Onset of anesthesia within 30 - 60 seconds and duration is typically 30-60 minutes
  • Pleasant taste
  • 14g bottle yields up to 34 full mouth applications
  • 30g bottle yields up to 73 full mouth applications
  • Cost-Efficient -
    • 14g bottle - $0.26 per quadrant and $1 a full mouth
    • 30g bottle - $0.18 per quadrant and $0.75 a full mouth
  • Measure and use only what you need - less waste*

Available in both a 14g and 30g bottle size, every package of Cetacaine Topical Anesthetic Liquid now includes a unique dispenser cap for the accurate filling of Luer-lock syringes. Cetacaine’s triple-active formula is well - suited for scaling and root planing, pre-injection, or other procedures requiring site specific topical anesthesia to accessible mucous membrane except the eyes. The unique design also allows for the single dip insertion of a microbrush through the Luer-lock cap.

Cetacaine is also available in spray and gel forms.
Rx only.

*Cetacaine Liquid in excess of 0.4mL per office visit is contraindicated

Important Safety Information
On rare occasions, methemoglobinemia has been reported in connection with the use of benzocaine-containing products. Care should be used not to exceed the maximum recommended dosage. If a patient becomes cyanotic, treat appropriately to counteract (such as with methylene blue, if medically indicated). The most common adverse reaction caused by local anesthetics is contact dermatitis characterized by erythema and pruritus that may progress to vesiculation and oozing. This occurs most commonly in patients following prolonged self-medication, which is contraindicated.

Cetacaine is not right for everyone, including those who are hypersensitive to any of its ingredients or are known to have cholinesterase deficiencies. Please see the brief summary of the Prescribing Information on page six.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Contraindications:
Active Ingredients: Benzocaine 14.0 %, Butamben 2.0 %, Tetracaine Hydrochloride 2.0 %

Hypersensitivity Reactions: Unpredictable adverse reactions (i.e. hypersensitivity, including anaphalaxis) are extremely rare. Localized allergic reactions may occur after prolonged or repeated use of any aminobenzoate anesthetic. The most common adverse reaction caused by local anesthetics is contact dermatitis characterized by erythema and pruritus that may progress to vesiculation and oozing. This occurs most commonly in patients following prolonged self-medication, which is contraindicated. If rash, urticaria, edema, or other manifestations of allergy develop during use, the drug should be discontinued. To minimize the possibility of a serious allergic reaction, Cetacaine preparations should not be applied for prolonged periods except under continual supervision. Dehydration of the epithelium or an escharotic effect may also result from prolonged contact.

Precaution: On rare occasions, methemoglobinemia has been reported in connection with the use of benzocaine-containing products. Care should be used not to exceed the maximum recommended dosage (see Dosage and Administration). If a patient becomes cyanotic, treat appropriately to counteract (such as with methylene blue, if medically indicated).

Use in Pregnancy: Safe use of Cetacaine has not been established with respect to possible adverse effects upon fetal development. Therefore, Cetacaine should not be used during early pregnancy, unless in the judgment of a physician, the potential benefits outweigh the unknown hazards.

Contraindications: Cetacaine is not suitable and should never be used for injection. Do not use in eyes. To avoid excessive systemic absorption, Cetacaine should not be applied to large areas of denuded or inflamed tissue. Cetacaine should not be administered to patients who are hypersensitive to any of its ingredients or to patients known to have cholinesterase deficiencies. Tolerance may vary with the status of the patient. Cetacaine should not be used under dentures or cotton rolls, as retention of the active ingredients under a denture or cotton roll could possibly cause an escharotic effect. Routine precaution for the use of any topical anesthetic should be observed when using Cetacaine.